Krestin - PharmaKB

Krestin

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2613 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Anemia	D000740	EFO_0004272	D64.9	21	110	134	41	31	325
Lymphoma	D008223	—	C85.9	61	176	42	7	15	274
Leukemia	D007938	—	C95	78	167	38	9	17	267
Neoplasms	D009369	—	C80	61	77	36	10	11	180
Myeloid leukemia acute	D015470	—	C92.0	59	105	24	3	10	175
Multiple myeloma	D009101	—	C90.0	46	100	27	2	13	172
Myelodysplastic syndromes	D009190	—	D46	48	104	21	2	11	159
Non-hodgkin lymphoma	D008228	—	C85.9	35	95	24	2	8	146
Breast neoplasms	D001943	EFO_0003869	C50	40	77	31	8	8	144
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	33	78	13	8	11	126

Show 123 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Hodgkin disease	D006689	—	C81	17	54	15	—	3	81
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	23	43	7	—	5	70
Large b-cell lymphoma diffuse	D016403	—	C83.3	21	41	12	—	5	69
Sarcoma	D012509	—	—	20	41	9	—	5	67
Ovarian neoplasms	D010051	EFO_0003893	C56	26	37	4	—	6	59
Mantle-cell lymphoma	D020522	—	C83.1	18	32	5	—	5	54
Myeloproliferative disorders	D009196	—	D47.1	19	30	4	—	6	53
Follicular lymphoma	D008224	—	C82	19	24	8	—	5	49
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	12	37	4	—	1	48
Central nervous system neoplasms	D016543	—	—	16	30	4	—	2	48

Show 226 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Fallopian tube neoplasms	D005185	—	—	9	9	—	—	3	19
Pancreatic neoplasms	D010190	EFO_0003860	C25	13	10	—	—	2	19
Glioma	D005910	EFO_0000520	—	13	8	—	—	—	19
Male breast neoplasms	D018567	—	—	8	10	—	—	—	14
Cytopenia	D000095542	—	—	1	4	—	—	9	14
Fanconi anemia	D005199	Orphanet_84	D61.03	6	10	—	—	2	14
Blast crisis	D001752	—	—	7	5	—	—	1	12
Stroke	D020521	EFO_0000712	I63.9	4	10	—	—	—	12
Oligodendroglioma	D009837	EFO_0000631	—	10	3	—	—	—	12
Type 1 diabetes mellitus	D003922	EFO_0001359	E10	4	7	—	—	2	11

Show 244 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Body weight	D001835	EFO_0004338	—	1	—	—	—	2	3
Pinealoma	D010871	—	—	3	—	—	—	—	3
Meningioma	D008579	EFO_0003098	D32.9	2	—	—	—	—	2
Hypertrophic pyloric stenosis	D046248	—	Q40.0	2	—	—	—	—	2
Mesothelioma	D008654	—	C45	1	—	—	—	1	2
Arthritis	D001168	EFO_0005856	M05-M14	1	—	—	—	1	2
Vasculitis	D014657	EFO_0006803	M31	1	—	—	—	1	2
Cerebrovascular disorders	D002561	EFO_0003763	I60-I69	1	—	—	—	1	2
End stage liver disease	D058625	EFO_1001311	K72.1	1	—	—	—	1	2
Myasthenia gravis	D009157	EFO_0004991	G70.0	2	—	—	—	—	2

Show 60 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Inflammatory bowel diseases	D015212	EFO_0003767	—	—	—	—	—	3	3
Hypoglycemia	D007003	—	E16.2	—	—	—	—	2	2
Chediak-higashi syndrome	D002609	Orphanet_167	D72.0	—	—	—	—	2	2
Ankylosing spondylitis	D013167	EFO_0003898	M45	—	—	—	—	2	2
Antiphospholipid syndrome	D016736	EFO_0002689	D68.61	—	—	—	—	2	2
Metabolic syndrome	D024821	EFO_0000195	E88.810	—	—	—	—	2	2
Anxiety disorders	D001008	EFO_0006788	F41.1	—	—	—	—	2	2
Feeding behavior	D005247	—	—	—	—	—	—	2	2
Hepatitis a	D006506	EFO_0007305	B15	—	—	—	—	2	2
Common cold	D003139	EFO_0007214	J00	—	—	—	—	2	2

Show 116 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—